# Observational Multicenter Study in Patients Receiving Chemotherapy and Amivantamab for Metastatic Non-small Cell Lung Cancer

> **NCT07563205** · — · RECRUITING · sponsor: **GFPC Investigation** · enrollment: 100 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer
- Non Small Cell Lung Cancer Metastatic
- Non Small Cell Lung Cancer NSCLC
- Non Small Cell Lung Carcinoma
- NSCLC
- EGFR
- EGFR Exon 20 Insertion Mutation
- EGFR Exon 19 Deletion Mutation
- EGFR Exon 21 Mutation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07563205
- **Lead sponsor:** GFPC Investigation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-19
- **Primary completion:** 2027-11-19
- **Final completion:** 2027-11-19
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07563205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07563205, "Observational Multicenter Study in Patients Receiving Chemotherapy and Amivantamab for Metastatic Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07563205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*